![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Manuscript received 10 April 1997. Initial reviews completed 9 June 1997. Revision accepted 12 September 1997.
Department of Biochemistry, College of Agricultural and Life Sciences, University of Wisconsin-Madison, Madison, WI 53706
1,25-Dihydroxycholecalciferol [1,25-(OH)2D3] has been shown to inhibit the progression of experimental autoimmune encephalomyelitis (EAE). Here we tested the possibility that 1,25-dihydroxycholecalciferol might be therapeutic for another autoimmune disease, arthritis. Two different animal models of arthritis were tested, namely, murine Lyme arthritis and collagen-induced arthritis. Infection of mice with Borrelia burgdorferi (the causative agent of human Lyme arthritis) produced acute arthritic lesions including footpad and ankle swelling. Supplementation with 1,25-dihydroxycholecalciferol of an adequate diet fed to mice infected with B. burgdorferi minimized or prevented these symptoms. Mice immunized with type II collagen also developed arthritis. The symptoms of this disease were also prevented by dietary supplementation with 1,25-dihydroxycholecalciferol. 1,25-Dihydroxycholecalciferol given to mice with early symptoms of collagen-induced arthritis prevented the progression to severe arthritis compared with untreated controls. These results suggest that 1,25-dihydroxycholecalciferol and/or its analogs may be a valuable treatment approach to this disease.
Key words: autoimmune disease, calcium, vitamin D, mice, lymphocytes.
The Journal of Nutrition Vol. 128 No. 1 January 1998,
pp. 68-72
Copyright ©1998 by the American Society for Nutritional Sciences
This article has been cited by other articles:
|
|
 |
|
  D. Muller and D. N. Muller Battle against the renin-angiotensin system: help from an unexpected party Nephrol. Dial. Transplant., April 1, 2009; 24(4): 1110 - 1112. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ranganathan Genetics of bone loss in rheumatoid arthritis--role of vitamin D receptor polymorphisms Rheumatology, April 1, 2009; 48(4): 342 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. R. Becklund, D. W. Hansen Jr., and H. F. DeLuca Enhancement of 1,25-dihydroxyvitamin D3-mediated suppression of experimental autoimmune encephalomyelitis by calcitonin PNAS, March 31, 2009; 106(13): 5276 - 5281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Misharin, M. Hewison, C.-R. Chen, V. Lagishetty, H. A. Aliesky, Y. Mizutori, B. Rapoport, and S. M. McLachlan Vitamin D Deficiency Modulates Graves' Hyperthyroidism Induced in BALB/c Mice by Thyrotropin Receptor Immunization Endocrinology, February 1, 2009; 150(2): 1051 - 1060. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Leventis and S. Patel Clinical aspects of vitamin D in the management of rheumatoid arthritis Rheumatology, November 1, 2008; 47(11): 1617 - 1621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bouillon, G. Carmeliet, L. Verlinden, E. van Etten, A. Verstuyf, H. F. Luderer, L. Lieben, C. Mathieu, and M. Demay Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice Endocr. Rev., October 1, 2008; 29(6): 726 - 776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K H Costenbader, D Feskanich, M Holmes, E W Karlson, and E Benito-Garcia Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women Ann Rheum Dis, April 1, 2008; 67(4): 530 - 535. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gorman, L. A. Kuritzky, M. A. Judge, K. M. Dixon, J. P. McGlade, R. S. Mason, J. J. Finlay-Jones, and P. H. Hart Topically Applied 1,25-Dihydroxyvitamin D3 Enhances the Suppressive Activity of CD4+CD25+ Cells in the Draining Lymph Nodes J. Immunol., November 1, 2007; 179(9): 6273 - 6283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ehrchen, L. Helming, G. Varga, B. Pasche, K. Loser, M. Gunzer, C. Sunderkotter, C. Sorg, J. Roth, and A. Lengeling Vitamin D receptor signaling contributes to susceptibility to infection with Leishmania major FASEB J, October 1, 2007; 21(12): 3208 - 3218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bailey, J. D. Cooper, L. Zeitels, D. J. Smyth, J. H.M. Yang, N. M. Walker, E. Hypponen, D. B. Dunger, E. Ramos-Lopez, K. Badenhoop, et al. Association of the Vitamin D Metabolism Gene CYP27B1 With Type 1 Diabetes Diabetes, October 1, 2007; 56(10): 2616 - 2621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Arnson, H. Amital, and Y. Shoenfeld Vitamin D and autoimmunity: new aetiological and therapeutic considerations Ann Rheum Dis, September 1, 2007; 66(9): 1137 - 1142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. E. Mullin and A. Dobs Vitamin D and Its Role in Cancer and Immunity: A Prescription for Sunlight Nutr Clin Pract, June 1, 2007; 22(3): 305 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Penna, S. Amuchastegui, C. Cossetti, F. Aquilano, R. Mariani, F. Sanvito, C. Doglioni, and L. Adorini Treatment of Experimental Autoimmune Prostatitis in Nonobese Diabetic Mice by the Vitamin D Receptor Agonist Elocalcitol J. Immunol., December 15, 2006; 177(12): 8504 - 8511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Holick High Prevalence of Vitamin D Inadequacy and Implications for Health Mayo Clin. Proc., March 1, 2006; 81(3): 353 - 373. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Helming, J. Bose, J. Ehrchen, S. Schiebe, T. Frahm, R. Geffers, M. Probst-Kepper, R. Balling, and A. Lengeling 1{alpha},25-dihydroxyvitamin D3 is a potent suppressor of interferon {gamma}-mediated macrophage activation Blood, December 15, 2005; 106(13): 4351 - 4358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nagpal, S. Na, and R. Rathnachalam Noncalcemic Actions of Vitamin D Receptor Ligands Endocr. Rev., August 1, 2005; 26(5): 662 - 687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Chen, M. T. Cencioni, D. F. Angelini, G. Borsellino, L. Battistini, and C. F. Brosnan Transcriptional Profiling of {gamma}{delta} T Cells Identifies a Role for Vitamin D in the Immunoregulation of the V{gamma}9V{delta}2 Response to Phosphate-Containing Ligands J. Immunol., May 15, 2005; 174(10): 6144 - 6152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-C. Souberbielle, V. Fayol, C. Sault, E. Lawson-Body, A. Kahan, and C. Cormier Assay-Specific Decision Limits for Two New Automated Parathyroid Hormone and 25-Hydroxyvitamin D Assays Clin. Chem., February 1, 2005; 51(2): 395 - 400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F Holick Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1678S - 1688S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. F DeLuca Overview of general physiologic features and functions of vitamin D Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1689S - 1696S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Wittke, V. Weaver, B. D. Mahon, A. August, and M. T. Cantorna Vitamin D Receptor-Deficient Mice Fail to Develop Experimental Allergic Asthma J. Immunol., September 1, 2004; 173(5): 3432 - 3436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F Holick Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis Am. J. Clinical Nutrition, March 1, 2004; 79(3): 362 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gregori, N. Giarratana, S. Smiroldo, M. Uskokovic, and L. Adorini A 1{alpha},25-Dihydroxyvitamin D3 Analog Enhances Regulatory T-Cells and Arrests Autoimmune Diabetes in NOD Mice Diabetes, May 1, 2002; 51(5): 1367 - 1374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cippitelli, C. Fionda, D. Di Bona, F. Di Rosa, A. Lupo, M. Piccoli, L. Frati, and A. Santoni Negative Regulation of CD95 Ligand Gene Expression by Vitamin D3 in T Lymphocytes J. Immunol., February 1, 2002; 168(3): 1154 - 1166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. F. DELUCA and M. T. CANTORNA Vitamin D: its role and uses in immunology FASEB J, December 1, 2001; 15(14): 2579 - 2585. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Cantorna, C. Munsick, C. Bemiss, and B. D. Mahon 1,25-Dihydroxycholecalciferol Prevents and Ameliorates Symptoms of Experimental Murine Inflammatory Bowel Disease J. Nutr., November 1, 2000; 130(11): 2648 - 2652. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Cantorna Vitamin D and Autoimmunity: Is Vitamin D Status an Environmental Factor Affecting Autoimmune Disease Prevalence? Experimental Biology and Medicine, March 1, 2000; 223(3): 230 - 233. [Abstract] [Full Text]
|
|
|
|
|
|
M. T. Cantorna, J. Humpal-Winter, and H. F. DeLuca Dietary Calcium Is a Major Factor in 1,25-Dihydroxycholecalciferol Suppression of Experimental Autoimmune Encephalomyelitis in Mice J. Nutr., November 1, 1999; 129(11): 1966 - 1971. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. A. Zager Calcitriol Directly Sensitizes Renal Tubular Cells to ATP-Depletion- and Iron-Mediated Attack Am. J. Pathol., June 1, 1999; 154(6): 1899 - 1909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J Smith, M. E Hayes, P. L Selby, and E B. Mawer Autocrine control of vitamin D metabolism in synovial cells from arthritic patients Ann Rheum Dis, June 1, 1999; 58(6): 372 - 378. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. JONES, S. A. STRUGNELL, and H. F. DeLUCA Current Understanding of the Molecular Actions of Vitamin D Physiol Rev, October 1, 1998; 78(4): 1193 - 1231. [Abstract] [Full Text] [PDF]
|
|
